GGrantIndex
Sort

141,003 grants matching cytokine

A Phase I Randomized Clinical Trial of a Novel Mucosal Recombinant H5 Influenza Vaccine with Nanoemulsion Adjuvant Followed by Parenteral Boost of Licensed Inactivated Influenza A H5N1 Vaccine

$771,638
Justin R. Ortiz · University Of Maryland Baltimore · U01 · FY2021 · AI

Project 3: Neurodevelopment in an NHP MIA model

$771,562
Melissa Dawn Bauman · University Of California At Davis · P50 · FY2021 · MH

Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy

$771,499
Alexander Marson · J. David Gladstone Institutes · R01 · FY2023 · CA

Innate immune responses to tissue infection by intestinal fungi inhibit wound repair

$771,486
Thaddeus S Stappenbeck · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AI

SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL

$771,475
Columbia University Health Sciences · P01 · FY2003 · CA

Inflammatory factors and kynurenine metabolites tracking suicidal behavior

$771,229
Lena Cecilia Brundin · Van Andel Research Institute · R01 · FY2023 · MH

Surrogate Biomarkers for Disease Progression in IPF

$771,211
Naftali Kaminski · Children'S Hosp Pittsburgh/Upmc Hlth Sys · P50 · FY2008 · HL

Parkin in mitochondrial dysfunction and airway inflammation of obese asthma

$771,182
Hong W Chu · National Jewish Health · R01 · FY2020 · AI

Combinatorial and computational design of bnAb mRNA vaccines for HIV

$771,167
Daniel G Anderson · Massachusetts Institute Of Technology · R33 · FY2025 · AI

Mitochondrial regulation of stress reactivity in humans

$771,149
Martin Picard · Columbia University Health Sciences · R01 · FY2022 · MH

Mitochondrial regulation of stress reactivity in humans

$771,149
Martin Picard · Columbia University Health Sciences · R01 · FY2023 · MH

Novel Biomarkers and Prediction Models for Rheumatoid Arthritis

$771,125
Elizabeth W Karlson · Brigham And Women'S Hospital · R01 · FY2015 · AR

Molecular Phenotypes within and across disease boundaries in IPF and COPD

$770,981
Naftali Kaminski · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL

The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening

$770,933
Stephen J. Jordan · Indiana University Indianapolis · R01 · FY2023 · AI

Clinical Trials of Immunotherapies for Childhood Cancer

$770,902
Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

CPML - Project 1: Genome-wide Studies of ALL Response

$770,856
Charles G. Mullighan · St. Jude Children'S Research Hospital · P50 · FY2015 · GM

Statistical Issues in AIDS Research

$770,776
James P Hughes · University Of Washington · R37 · FY2019 · AI

Efficacy of Aspirin & Naproxen in Colorectal Cancer Models

$770,768
University Of Oklahoma Hlth Sciences Ctr · N01 · FY2012 · CA

Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison

$770,748
Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

The development of a recombinant vaccine against human onchocerciasis

$770,747
Sara Lustigman · New York Blood Center · R01 · FY2017 · AI

Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling

$770,727
Vishal Nigam · Seattle Children'S Hospital · R01 · FY2025 · HD

Effect of immunization route and prior immunity for a live attenuated varicella AIDS vaccine

$770,726
Vicki L Traina-Dorge · Tulane University Of Louisiana · R01 · FY2019 · AI

Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms

$770,698
Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · MH

Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV

$770,678
Kenneth W Witwer · Johns Hopkins University · R01 · FY2023 · AI

HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment

$770,664
William J Britt · University Of Alabama At Birmingham · R01 · FY2020 · AI